On June 15th, 2004, FDA’s Medical Devices Panel recommended that the U.S. Food and Drug Administration approve vagus nerve stimulation as a therapy for chronic or recurrent treatment-resistant depression. I was at the meeting, seated in the first row and made a presentation to the Panel. Senate Finance Committee Delays FDA Approval of Vagus Nerve Stimulation Therapy for Depression - Updates
Leave a Comment